by Karen O'Hanlon Cohrt | Mar 22, 2018 | Trends
In one of our recent posts, we addressed the types of genetic variability that exist in humans and why a greater understanding of these is critical in diagnostics, for predicting our response to new drugs, and in the development of personalized treatments. Here, we...
by Karen O'Hanlon Cohrt | Mar 4, 2018 | Disease Models
Most of us were introduced to phagocytosis as a cellular event where dead host cells, microbial cells or their components, or other foreign bodies are engulfed and often destroyed by specialized cells known as phagocytes. During my undergraduate studies, phagocytosis...
by Karen O'Hanlon Cohrt | Feb 20, 2018 | Trends
Genetic variability can be defined as the genetic differences that exist within or between populations of individuals, and explains the remarkable differences between humans, despite the fact that we share 99.5 % of our DNA with each other. Genetic variability...
by Karen O'Hanlon Cohrt | Jan 31, 2018 | Disease Models
For anyone who has studied biology, macrophages have most likely been on your reading list at one point or another. Microglia on the other hand are less likely to feature on your undergraduate syllabus (or else I’m older than I like to admit!). In this post, we...
by Karen O'Hanlon Cohrt | Jan 4, 2018 | Disease Models
Anyone who follows popular science news will have noticed that mesenchymal stem cells (MSCs) have gained traction in recent years. Alleviating chronic back pain, enabling stroke sufferers to walk again, manmade tracheas and a cure for Crohn’s disease – these are just...
